varenicline has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Brestec, AL; Couturaud, F; Dansou, A; Dewitte, JD; Dion, A; Gagnadoux, F; Hayem-Vannimenus, C; Jouneau, S; Larhantec, G; Le Mao, R; Leroyer, C; Magnan, A; Paleiron, N; Proust, A; Roche, N; Sanchez, O; Tromeur, C | 1 |
| Daniil, Z; Gourgoulianis, KI; Hatzoglou, C; Ioannidis, V; Politis, A | 1 |
| Abe, Y; Imai, T; Katayama, K; Kusakabe, A; Nawa, T; Ohkawa, K; Sakakibara, M | 1 |
| Au, DH; Collins, MP; Feemster, LC; Melzer, AC | 1 |
| Cerimele, JM; Durango, A | 1 |
| Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C | 1 |
| Bhattaram, VA; Bonapace, C; Chilukuri, DM; Duan, JZ; Garnett, C; Gobburu, JV; Jang, SH; Kenna, L; Lesko, LJ; Madabushi, R; Men, Y; Powell, JR; Qiu, W; Ramchandani, RP; Tornoe, CW; Wang, Y; Zheng, JJ | 1 |
2 review(s) available for varenicline and Disease Exacerbation
| Article | Year |
|---|---|
Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
Topics: Adverse Drug Reaction Reporting Systems; Attention; Benzazepines; Cognition Disorders; Disease Progression; Dose-Response Relationship, Drug; Humans; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quinoxalines; Risk Factors; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2011 |
2 trial(s) available for varenicline and Disease Exacerbation
| Article | Year |
|---|---|
Effect of Early Initiation of Varenicline on Smoking Cessation in COPD Patients Admitted for Exacerbation: The Save Randomized Clinical Trial.
Topics: Aged; Counseling; Disease Progression; Early Medical Intervention; Female; Hospitalization; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference
Topics: Adult; Aftercare; Asthma; Behavior Therapy; Combined Modality Therapy; Community-Acquired Infections; Comorbidity; Disease Progression; Female; Hospitalization; Humans; Inpatients; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Motivational Interviewing; Odds Ratio; Patient Preference; Pneumonia; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Referral and Consultation; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2018 |
3 other study(ies) available for varenicline and Disease Exacerbation
| Article | Year |
|---|---|
Two-step progression of varenicline-induced autoimmune hepatitis.
Topics: Chemical and Drug Induced Liver Injury; Disease Progression; Female; Hepatitis, Autoimmune; Humans; Liver; Lymphocytes; Middle Aged; Nicotinic Agonists; Recurrence; Smoking Cessation; Varenicline; Withholding Treatment | 2018 |
Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Admission; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; United States Department of Veterans Affairs; Varenicline | 2016 |
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.
Topics: Benzazepines; Clinical Trials as Topic; Cyclosporins; Data Collection; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Approval; Drug Evaluation; Drug Labeling; Echinocandins; Everolimus; Humans; Investigational New Drug Application; Lipopeptides; Lipoproteins; Micafungin; Peer Review; Peptides, Cyclic; Pharmacokinetics; Pharmacology, Clinical; Quinoxalines; Risk Assessment; Sirolimus; Treatment Outcome; United States; United States Food and Drug Administration; Varenicline | 2007 |